Poloxamer 188 Protects Neurons against Ischemia/Reperfusion Injury through Preserving Integrity of Cell Membranes and Blood Brain Barrier

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Gu, Jin Hua ^a,b   Ge, Jian Bin ^a,c   Li, Mei ^a   Xu, Hai Dong ^a   Wu, Feng ^a,b   Qin, Zheng Hong ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

^c The Second People's Hospital of Nantong   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; POLOXAMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY EQUILIBRIUM; BRAIN ATROPHY; BRAIN EDEMA; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN WATER; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; GRIP STRENGTH; HIPPOCAMPUS; IN VIVO STUDY; MALE; MEMBRANE RUPTURE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR DYSFUNCTION; MOUSE; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; REPERFUSION INJURY; SURVIVAL RATE;

ANIMALS; BLOOD-BRAIN BARRIER; CELL MEMBRANE; MALE; MICE; MICE, INBRED ICR; NEURONS; OCTOXYNOL; POLOXAMER; REPERFUSION INJURY;

EID: 84876177830     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061641     Document Type: Article

References (34)

1. Donnan GA, Fisher M, Macleod M, Davis SM, (2008) Stroke. Lancet 371: 1612-1623.
2. Maskarinec SA, Wu G, Lee KY, (2005) Membrane sealing by polymers. Ann N Y Acad Sci 1066: 310-320.
3. Murphy AD, McCormack MC, Bichara DA, Nguyen JT, Randolph MA, et al. (2010) Poloxamer 188 protects against ischemia-reperfusion injury in a murine hind-limb model. Plast Reconstr Surg 125: 1651-1660.
4. Walters TJ, Mase VJ, Roe JL, Dubick MA, Christy RJ, (2011) Poloxamer-188 Reduces Muscular Edema After Tourniquet-Induced Ischemia-Reperfusion Injury in Rats. The Journal of Trauma: Injury, Infection, and Critical Care 70: 1192-1197.
5. Lee RC, River LP, Pan FS, Ji L, Wollmann RL, (1992) Surfactant-induced sealing of electropermeabilized skeletal muscle membranes in vivo. Proc Natl Acad Sci U S A 89: 4524-4528.
6. Greenebaum B, (2004) Poloxamer 188 prevents acute necrosis of adult skeletal muscle cells following high-dose irradiation. Burns 30: 539-547.
7. Padanilam JT, Bischof JC, Lee RC, Cravalho EG, Tompkins RG, et al. (1994) Effectiveness of poloxamer 188 in arresting calcein leakage from thermally damaged isolated skeletal muscle cells. Ann N Y Acad Sci 720: 111-123.
8. Marks JD, Pan CY, Bushell T, Cromie W, Lee RC, (2001) Amphiphilic, tri-block copolymers provide potent membrane-targeted neuroprotection. FASEB J 15: 1107-1109.
9. Serbest G, Horwitz J, Barbee K, (2005) The effect of poloxamer-188 on neuronal cell recovery from mechanical injury. J Neurotrauma 22: 119-132.
10. Serbest G, Horwitz J, Jost M, Barbee K, (2006) Mechanisms of cell death and neuroprotection by poloxamer 188 after mechanical trauma. FASEB J 20: 308-310.
11. Kilinc D, Gallo G, Barbee KA, (2008) Mechanically-induced membrane poration causes axonal beading and localized cytoskeletal damage. Exp Neurol 212: 422-430.
12. Kilinc D, Gallo G, Barbee KA, (2009) Mechanical membrane injury induces axonal beading through localized activation of calpain. Exp Neurol 219: 553-561.
13. Borgens RB, Bohnert D, Duerstock B, Spomar D, Lee RC, (2004) Subcutaneous tri-block copolymer produces recovery from spinal cord injury. J Neurosci Res 76: 141-154.
14. Curry DJ, Wright DA, Lee RC, Kang UJ, Frim DM, (2004) Poloxamer 188 volumetrically decreases neuronal loss in the rat in a time-dependent manner. Neurosurgery 55: 943-948.
15. Frim DM, Wright DA, Curry DJ, Cromie W, Lee R, et al. (2004) The surfactant poloxamer-188 protects against glutamate toxicity in the rat brain. Neuroreport 15: 171-174.
16. Cadichon SB, Le Hoang M, Wright DA, Curry DJ, Kang U, et al. (2007) Neuroprotective effect of the surfactant poloxamer 188 in a model of intracranial hemorrhage in rats. J Neurosurg 106: 36-40.
17. Singh-Joy SD, McLain VC, (2008) Safety assessment of poloxamers 101, 105, 108, 122, 123, 124, 181, 182, 183, 184, 185, 188, 212, 215, 217, 231, 234, 235, 237, 238, 282, 284, 288, 331, 333, 334, 335, 338, 401, 402, 403, and 407, poloxamer 105 benzoate, and poloxamer 182 dibenzoate as used in cosmetics. Int J Toxicol 27Suppl 2: 93-128.
18. Colbassani HJ, Barrow DL, Sweeney KM, Bakay RA, Check IJ, et al. (1989) Modification of acute focal ischemia in rabbits by poloxamer 188. Stroke 20: 1241-1246.
19. Clark WM, Lessov NS, Dixon MP, Eckenstein F, (1997) Monofilament intraluminal middle cerebral artery occlusion in the mouse. Neurol Res 19: 641-648.
20. Mdzinarishvili A, Kiewert C, Kumar V, Hillert M, Klein J, (2007) Bilobalide prevents ischemia-induced edema formation in vitro and in vivo. Neuroscience 144: 217-222.
21. Longa EZ, Weinstein PR, Carlson S, Cummins R, (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20: 84-91.
22. Gertz K, Priller J, Kronenberg G, Fink KB, Winter B, et al. (2006) Physical activity improves long-term stroke outcome via endothelial nitric oxide synthase-dependent augmentation of neovascularization and cerebral blood flow. Circ Res 99: 1132-1140.
23. Matsuura K, Kabuto H, Makino H, Ogawa N, (1997) Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion. J Neurosci Methods 73: 45-48.
24. Unal Cevik I, Dalkara T, (2003) Intravenously administered propidium iodide labels necrotic cells in the intact mouse brain after injury. Cell Death and Differentiation 10: 928-929.
25. Whalen MJ, Dalkara T, You Z, Qiu J, Bermpohl D, et al. (2007) Acute plasmalemma permeability and protracted clearance of injured cells after controlled cortical impact in mice. Journal of Cerebral Blood Flow & Metabolism 28: 490-505.
26. Uyama O, Okamura N, Yanase M, Narita M, Kawabata K, et al. (1988) Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence. J Cereb Blood Flow Metab 8: 282-284.
27. Polavarapu R, Gongora MC, Winkles JA, Yepes M, (2005) Tumor necrosis factor-like weak inducer of apoptosis increases the permeability of the neurovascular unit through nuclear factor-kappa B pathway activation. J Neurosci 25: 10094-10100.
28. Schaer GL, Hursey TL, Abrahams SL, Buddemeier K, Ennis B, et al. (1994) Reduction in reperfusion-induced myocardial necrosis in dogs by RheothRx injection (poloxamer 188 N.F.), a hemorheological agent that alters neutrophil function. Circulation 90: 2964-2975.
29. Palmer JS, Cromie WJ, Lee RC, (1998) Surfactant administration reduces testicular ischemia-reperfusion injury. J Urol 159: 2136-2139.
30. Follis F, Jenson B, Blisard K, Hall E, Wong R, et al. (1996) Role of poloxamer 188 during recovery from ischemic spinal cord injury: a preliminary study. J Invest Surg 9: 149-156.
31. Gaymalov ZZ, Yang Z, Pisarev VM, Alakhov VY, Kabanov AV, (2009) The effect of the nonionic block copolymer pluronic P85 on gene expression in mouse muscle and antigen-presenting cells. Biomaterials 30: 1232-1245.
32. Li C-H, Wang Y, Qin Z-H, (2011) Neuroprotective effects of surfactant poloxamer 188 in excitotoxcity and underlying mechanisms. Chinese Pharmacological Bulletin 26: 10.
33. Bond M, Fabunmi RP, Baker AH, Newby AC, (1998) Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett. 435: 29-34.
34. Farina AR, Tacconelli A, Vacca A, Maroder M, Gulino A, et al. (1999) Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor kappaB elements. Cell Growth Differ 10: 353-367.